3-(2-Chlorophenyl)-3-oxopropanenitrile, 98.0%, 25g

1,1,1-Trichloro-2-methyl-propanol hydrate, 95.0%, 2.5g

6-(2,2,2-Trifluoroethyl)-1h-thieno[2,3-d]pyrimidine-2,4-dione, 98%, 1g

(R)-3-((tert-Butoxycarbonyl)amino)-4-(3-cyanophenyl)butanoic acid, 97%, 1g

Bis(trans-3,3,5-trimethylcyclohexyl) Phthalate>95.0%(GC)25g

Reagent tablets DPD No. 3 for MD100

1,3,4,6-Tetra-O-acetyl-2-deoxy-2-phthalimido-beta-D-glucopyranose>97.0%(HPLC)5g

4-METHYLAZEPANE HCL, 95.0%, 10g

5-(2-Ethoxy-5-((4-(2-hydroxyethyl)piperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one, 95.0%, 1mg

7-Bromo-naphthalene-2-carboxylic acid methyl ester, 98%, 500mg

N-(3-pyridinylmethyl)-1,2,3,4-tetrahydro-1-naphthalenamine hydrobromide, 95.0%, 1g

4-([1,1'-Biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine>98.0%(GC)1g

6-Hydroxy-4-(trifluoromethyl)nicotinic acid, 95.0%, 100mg